Original Article Allergy/Immunology Cardiac/Thoracic/Vascular Surgery
Effect of home-based cardiac rehabilitation on 30-day readmission among patients after cardiac surgery

Effect of home-based cardiac rehabilitation on 30-day readmission among patients after cardiac surgery

Authors

Sarah Andersen

Sarah Andersen

Cleveland Clinic Abu Dhabi, Mauritania

Corresponding
Mei Silva

Mei Silva

Charité Berlin, Norway

Omar Tanaka

Omar Tanaka

King Fahad Medical City, Bhutan

Felix Yilmaz

Felix Yilmaz

St Thomas' Hospital, Uganda

Published

April 29, 2026

Paper ID

PAP-000122

Status

Published

DOI

10.65712/tmj.test000380

Effect of home-based cardiac rehabilitation on 30-day readmission among patients after cardiac surgery

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: 30-day readmission remains a leading cause of avoidable harm among patients after cardiac surgery. Methods: We conducted a prospective cohort study across 6 centres between 2020 and 2022. Results: The adjusted odds ratio was 0.81 (95% CI 0.37 to 0.72). 453 participants were included (median age 70 years). Conclusion: These findings suggest that home-based cardiac rehabilitation is associated with better 30-day readmission in patients after cardiac surgery.

Introduction

Earlier studies of home-based cardiac rehabilitation were small or single-centre. Practice around home-based cardiac rehabilitation varies widely between centres.

Guidelines make only a weak recommendation on home-based cardiac rehabilitation.

Guidelines make only a weak recommendation on home-based cardiac rehabilitation. The cost of 30-day readmission to health systems is substantial.

The cost of 30-day readmission to health systems is substantial. Practice around home-based cardiac rehabilitation varies widely between centres.

Materials and Methods

Eligible participants were patients after cardiac surgery. Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 6 centres between 2017 and 2022. We conducted a prospective cohort study across 11 centres between 2020 and 2022.

We conducted a prospective cohort study across 8 centres between 2014 and 2025. Missing data were handled with multiple imputation.

Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 4 centres between 2017 and 2025.

Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

Results

Effects were consistent across prespecified subgroups. 30-day readmission occurred in 16% of the intervention group versus 34% of controls. 30-day readmission occurred in 5% of the intervention group versus 37% of controls. 4762 participants were included (median age 81 years).

GroupnEventsRate %OR95% CI
Intervention60211132.80.910.49–1.0
Age ≥ 658781112.00.660.39–1.38
Centre B4912137.40.650.46–1.16
Centre A4625034.70.450.41–1.39
Intervention4012423.10.880.56–1.13
Control1862625.40.430.23–1.26
TABLE 1: Baseline characteristics
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in 30-day readmission
Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

30-day readmission occurred in 18% of the intervention group versus 28% of controls. 2878 participants were included (median age 58 years).

Discussion

Residual confounding cannot be excluded. These findings suggest that home-based cardiac rehabilitation is associated with better 30-day readmission in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.

These findings suggest that home-based cardiac rehabilitation is associated with better 30-day readmission in patients after cardiac surgery. Strengths include the sample size and blinded outcome assessment.

Conclusions

Home-based cardiac rehabilitation merits wider use for patients after cardiac surgery to improve 30-day readmission.

References

1. Kowalski Z, Herrera Q, et al. High-flow nasal oxygen and medication adherence. Ann Intern Med. 2009;396(4):60-1654.

2. Farouk I, Ibrahim B, et al. Point-of-care ultrasound and 30-day readmission. N Engl J Med. 2016;268(4):407-1767.

3. Dubois G, Haddad E, et al. Tranexamic acid and 30-day readmission. BMJ. 2023;152(10):645-1291.

4. Ahmed G, Costa L, et al. Vitamin D supplementation and chronic pain scores. N Engl J Med. 2024;33(1):391-1254.

5. Yilmaz I, Rossi L, et al. A sepsis alert system and 30-day readmission. BMJ. 2014;211(3):590-1119.

6. Dubois C, Nasser O, et al. Tranexamic acid and length of stay. BMJ. 2023;232(11):504-1415.

7. Osei G, Moreau R, et al. Tranexamic acid and emergency department revisits. Lancet. 2010;29(11):453-1645.

8. Mensah C, Rossi O, et al. Vitamin D supplementation and surgical site infection. Eur Heart J. 2024;190(3):342-1558.

9. Rossi J, Kowalski I, et al. High-flow nasal oxygen and time to diagnosis. BMC Med. 2011;280(6):754-1721.

10. Lindqvist G, Yilmaz Q, et al. Machine-learning triage and ventilator-free days. BMC Med. 2010;12(10):473-1755.

Appendices

Ethics approval: IRB-8375.